Skip to main content

David Steeb, Pharm.D, MPH, promoted to associate professor in Division of Practice Advancement and Clinical Education

September 15, 2021

David Steeb, Pharm.D., M.P.H., has been promoted to associate professor in the UNC Eshelman School of Pharmacy’s Division of Practice Advancement and Clinical Education (PACE), effective July 1. “I’m honored to receive this promotion and want to thank all of my collaborators and mentors who helped get me here. I look forward to further advancing global health education and training both locally and globally.” Steeb said. Steeb also serves as the School’s director of global engagement and adjunct senior lecturer at Monash University Faculty of Pharmacy and Pharmaceutical Sciences in Melbourne, Australia. He received his Bachelor of Science in chemistry … Continued

Innovations and Transformations in Pharmaceutical Sciences 2021 conference attracts participants from around world, dives into topics of drugs, vaccines

September 10, 2021

For three weeks in July, the UNC Eshelman School of Pharmacy virtually hosted its Innovations and Transformations in Pharmaceutical Sciences 2021 conference. The annual conference was geared toward current and future scientists to learn about the discovery, delivery, and clinical use of drugs and vaccines – a topic of critical importance during the COVID-19 pandemic. “This program provides an opportunity for a diverse group of faculty to educate on different pharmaceutical science topics. We also are able to utilize our graduate students to gain valuable teaching skills and provide tips on how to prepare oneself for graduate school,” said conference … Continued

Third-year student Jacob Robinson receives AFPE Gateway to Research Award

September 8, 2021

Jacob Robinson, MS, a third year Pharm.D. student, was recently honored with the American Foundation for Pharmaceutical Education (AFPE) Gateway to Research Award. The Gateway scholarship provides a unique opportunity for Pharm.D. and baccalaureate degree students to participate in a faculty-mentored research project. The award aims to help students learn how to identify relevant research problems, generate a research hypothesis, analyze data, interpret and use research results in practice, effectively communicate research and clinical data to a broad audience, develop problem-solving skills, and sharpen critical thinking skills. The exposure to and understanding of research enables students to improve their clinical … Continued

Kristy Ainslie works to develop new therapy for glioblastoma patients, receives $1.7 million from NIH to pursue research

September 1, 2021

The National Institutes of Health’s National Cancer Institute has awarded Kristy Ainslie, Ph.D. with a $1,761,616 grant to develop a new therapy for glioblastoma – the most common primary brain tumor in the United States. Glioblastoma accounts for 48 percent of all primary malignant brain tumors, with more than 13,000 people in the United States diagnosed each year, according to the National Brain Tumor Society. Even with surgical resection, radiation, and chemotherapy, the median survival remains of only 12-15 months, and about 10,000 Americans die from the disease each year. Ainslie’s five-year award will support her work, “Tunable Temporal Drug … Continued

Alexander Kabanov receives millions from NIH to develop effective therapeutics for triple-negative breast cancer

August 27, 2021

Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., recently received funding from the National Institutes of Health’s National Cancer Institute to help combat triple-negative breast cancer, a disease that has fewer treatment options than other types of breast cancer. The four-year funding totaling $2,452,236 will support his project, “Toward Translation of Nanoformulated Paclitaxel-Platinum Combination.” The goal of Kabanov’s project is to obtain pre-clinical data to enable the translation of a novel nanotechnology-based immunotherapeutic drug to treat triple-negative breast cancer. The disease is currently associated with a poor prognosis, and according to the American Cancer Society, the 5-year relative survival rate is 77%. Through his … Continued

Top pharmacy school sets new standard of learning with CIPhER program 

August 25, 2021

UNC Eshelman School of Pharmacy launches online teaching certificate program  The UNC Eshelman School of Pharmacy’s Center for Innovative Pharmacy Education and Research (CIPhER) has launched an online Teaching & Learning Certificate Program that sets a new standard in pharmacy education and professional development.  As the No. 1 school of pharmacy in the U.S., the UNC Eshelman School of Pharmacy and CIPhER are committed to delivering innovative, dynamic education programs for pharmacy residents and pharmacy educators across the country.   The program was developed by renowned CIPhER faculty to meet the needs and demands of today’s faculty, preceptors, and residents. Designed as a customized learning experience, the self-paced program delivers a world-class curriculum focused on evidence-based teaching … Continued

Popular Netflix show inspires alum in creation of her COVID-19 public service announcement for World Health Organization

August 20, 2021

In this alum spotlight, we chat with Ina Liu, Pharm.D., MS (’18, ’20), Clinical Manager at UNC Hospitals at WakeBrook, a behavioral health facility. Recently, Liu participated in a World Health Organization contest to develop a public service announcement to increase awareness of COVID-19 safety precautions. Liu, who won the PSA contest, developed a public service announcement that aimed to “checkmate” COVID-19 transmission. Learn more about where she found her inspiration: Q: What prompted you to participate in the World Health Organization (WHO) contest? A: I have always had a very strong interest in the intersection of art and healthcare … Continued

School partners with University of North Carolina Wilmington to train future pharmacists

August 16, 2021

The University of North Carolina Wilmington is collaborating with the UNC Eshelman School of Pharmacy in a shared commitment to train the future public health workforce. The two universities are creating an Early Assurance Program, offering an automatic interview with the UNC Eshelman School of Pharmacy’s Doctor of Pharmacy (Pharm.D.) program admissions committee for qualifying UNCW students. UNCW will verify that interested students meet the participation qualifications identified by the two schools and provide processes and resources to support interested students. “Each of our universities are committed to engaging with our communities to improve the health of North Carolinians, so … Continued

Meet alumna Irene Ulrich, clinical pharmacist at MAHEC

August 13, 2021

In this alum spotlight, we chat with Irene Park Ulrich, Pharm.D., BCACP, clinical pharmacist in the Mountain Area Heath Education Center’s Department of Family Medicine, and associate professor of clinical education at the UNC Eshelman School of Pharmacy. Please describe your novel practice setting. What makes your career path unique?    MAHEC is a multidisciplinary health care institution in Western North Carolina. I work in the Family Medicine Department and practice at 2 of the MAHEC satellite practices alongside family medicine physicians. I practice under a collaborative practice agreement, and have my clinical pharmacist practitioner (CPP) designation in North Carolina. In both … Continued

Carolina scientists testing contraception that stops sperm in its tracks

August 11, 2021

University of North Carolina Eshelman School of Pharmacy has developed a panel of ultrapotent sperm-binding monoclonal antibodies as option for affordable, non-hormonal female contraception Scientists at the University of North Carolina at Chapel Hill are engineering molecularly tuned monoclonal antibodies that can be directly delivered into the vagina for a new type of non-hormonal female contraception. Monoclonal antibodies are known for their ability to fight off invading germs, and are used to treat and prevent everything from cancer to COVID-19. Scientists are now enabling a new application for antibodies: blocking sperm from reaching an egg. The concept is taking shape … Continued